Desonide Gel
NDC Package 24470-920-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Desonide gel is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). This formulation utilizes a gel delivery system. Marketed by Cintex Services, Llc, this product is identified by NDC 24470-920 and is authorized under FDA application ANDA202470.

Identification & Billing

NDC Package Code
24470-920-60
Package Description
1 TUBE in 1 CARTON / 60 g in 1 TUBE
Product Code
24470-920
11-Digit Billing Format
24470092060
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
60 GM
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Desonide
Non-Proprietary Name
Desonide
Substance Name
Desonide
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
DESONIDE .5 mg/g
Pharmacologic Class
Usage Information
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Desonide reduces the swelling, itching and redness that can occur in these types of conditions. Desonide is a mild corticosteroid.

Regulatory & Marketing

Labeler Name
Cintex Services, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA202470
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-09-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24470-920-60 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Desonide, a human prescription drug labeled by Cintex Services, Llc. This product is billed per "GM" gram and contains an estimated amount of 60 billable units per package. This gel is formulated for topical use and contains desonide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cintex Services, Llc on July 09, 2020. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Desonide reduces the swelling, itching and redness that can occur in these types of conditions. Desonide is a mild corticosteroid.

How is this Cintex Services, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24470092060. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24470-920-60
11-Digit CMS (5-4-2)
24470-0920-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.